tiprankstipranks
Nissha Co.Ltd. (JP:7915)
:7915

Nissha Co.Ltd. (7915) AI Stock Analysis

0 Followers

Top Page

JP:7915

Nissha Co.Ltd.

(7915)

Select Model
Select Model
Select Model
Neutral 56 (OpenAI - 5.2)
Rating:56Neutral
Price Target:
¥1,235.00
▼(-1.20% Downside)
Action:ReiteratedDate:02/18/26
The score is driven primarily by improving fundamentals since 2023, but tempered by sharply weaker 2025 profitability and rising leverage. Technicals are mildly supportive with neutral momentum, while the high P/E valuation offsets the benefit of the dividend yield.
Positive Factors
Recovering free cash flow
Free cash flow recovery from negative in 2023 to sharply positive in 2025 indicates the business can internally fund operations and selective reinvestment. Durable cash generation reduces reliance on external financing, supporting capex, dividends, or debt paydown over the medium term.
Negative Factors
Compressed and weakening profitability
Very low net margins and sharply reduced returns on equity point to limited earnings power and low buffer against cost shocks. Persistently compressed profitability constrains reinvestment capacity, heightens sensitivity to volume swings, and raises questions about sustainable competitive economics.
Read all positive and negative factors
Positive Factors
Negative Factors
Recovering free cash flow
Free cash flow recovery from negative in 2023 to sharply positive in 2025 indicates the business can internally fund operations and selective reinvestment. Durable cash generation reduces reliance on external financing, supporting capex, dividends, or debt paydown over the medium term.
Read all positive factors

Nissha Co.Ltd. (7915) vs. iShares MSCI Japan ETF (EWJ)

Nissha Co.Ltd. Business Overview & Revenue Model

Company Description
Nissha Co., Ltd. engages in industrial materials, devices, medical technologies, and information and communication in Japan and internationally. The company provides in-mold decoration technology, in-mold electronics, transfer foil, printed electr...
How the Company Makes Money
null...

Nissha Co.Ltd. Financial Statement Overview

Summary
Revenue and free cash flow recovered strongly from the 2023 trough, but profitability deteriorated in 2025 (net margin ~0.5% and weaker ROE), and leverage has been rising (debt-to-equity up to ~0.72). Fundamentals are improving, but margin stability and cash conversion remain key risks.
Income Statement
54
Neutral
Balance Sheet
62
Positive
Cash Flow
57
Neutral
BreakdownDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue194.90B195.60B167.73B193.96B189.28B
Gross Profit43.70B43.80B32.62B42.42B44.47B
EBITDA15.65B15.33B8.20B22.78B29.73B
Net Income1.00B3.86B-2.99B10.14B15.86B
Balance Sheet
Total Assets250.12B250.78B217.85B230.21B209.27B
Cash, Cash Equivalents and Short-Term Investments39.21B50.97B37.86B54.50B42.34B
Total Debt73.80B72.78B55.77B57.55B49.95B
Total Liabilities132.24B135.26B106.99B118.69B111.01B
Stockholders Equity115.32B114.17B110.91B111.55B98.28B
Cash Flow
Free Cash Flow3.98B5.55B-3.99B5.97B11.13B
Operating Cash Flow10.34B12.31B1.49B12.04B18.79B
Investing Cash Flow-16.74B-11.43B-8.02B-4.38B-6.87B
Financing Cash Flow-5.47B9.15B-12.63B1.08B2.61B

Nissha Co.Ltd. Technical Analysis

Technical Analysis Sentiment
Positive
Last Price1250.00
Price Trends
50DMA
1288.52
Positive
100DMA
1254.78
Positive
200DMA
1290.20
Positive
Market Momentum
MACD
-0.87
Negative
RSI
53.83
Neutral
STOCH
81.30
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7915, the sentiment is Positive. The current price of 1250 is below the 20-day moving average (MA) of 1261.30, below the 50-day MA of 1288.52, and below the 200-day MA of 1290.20, indicating a bullish trend. The MACD of -0.87 indicates Negative momentum. The RSI at 53.83 is Neutral, neither overbought nor oversold. The STOCH value of 81.30 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:7915.

Nissha Co.Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
78
Outperform
¥693.42B15.508.07%2.85%11.18%-0.75%
74
Outperform
¥594.07B16.106.30%2.16%1.90%-105.45%
71
Outperform
¥1.12T20.8515.75%1.08%19.45%41.03%
70
Outperform
¥398.45B14.112.18%-6.10%-7.03%
61
Neutral
$37.18B12.37-10.20%1.83%8.50%-7.62%
56
Neutral
¥60.39B59.150.90%4.00%0.12%-105.94%
56
Neutral
¥637.10B15.622.57%4.81%-49.43%
* Technology Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:7915
Nissha Co.Ltd.
1,292.00
198.34
18.14%
JP:6806
HIROSE ELECTRIC CO
21,100.00
6,297.53
42.54%
JP:5214
Nippon Electric Glass Co
7,365.00
4,328.06
142.51%
JP:4186
Tokyo Ohka Kogyo Co
9,659.00
6,813.64
239.46%
JP:4980
Dexerials Corp.
2,373.00
916.84
62.96%
JP:6976
Taiyo Yuden Co., Ltd.
5,279.00
3,245.55
159.61%

Nissha Co.Ltd. Corporate Events

Nissha Delays Vietnam Medical Device Subsidiary Acquisition to April–May 2026
Mar 31, 2026
Nissha Co., Ltd. has postponed the scheduled execution date of its planned share acquisition of Vietnam’s USM Healthcare Medical Devices Factory Joint Stock Company, shifting the expected closing from March 2026 to between April and May 2026...
Nissha Revises 2025 Cash Flow Figures After Discovering Reporting Errors
Mar 23, 2026
Nissha Co., Ltd. announced it has corrected errors in its previously released consolidated financial results for the fiscal year ended December 31, 2025, specifically in the consolidated statements of cash flows and related information. The primar...
Nissha Beats FY2025 Forecasts on M&A and FX Gains but Trails Prior-Year Profits
Feb 12, 2026
Nissha reported that its fiscal 2025 results modestly exceeded its prior forecast, with net sales rising to ¥194.9 billion and operating profit reaching ¥4.0 billion, supported by steady demand in its Industrial Materials, Devices, and M...
Nissha Maintains Dividend as 2025 Profit Slumps, Forecasts Earnings Rebound in 2026
Feb 12, 2026
Nissha reported essentially flat net sales of ¥194.9 billion for the year ended December 31, 2025, but saw a sharp deterioration in profitability, with operating profit down 26% to ¥4.0 billion and profit attributable to owners of the pa...
Nissha to Acquire Vietnam’s USM Healthcare, Expanding Medical Device Footprint in Southeast Asia
Jan 23, 2026
Nissha Co., Ltd. has decided to acquire 60% of the shares of USM Healthcare Medical Devices Factory Joint Stock Company, a Ho Chi Minh City–based manufacturer of cardiology stents and orthopedic devices, thereby making it a subsidiary and sp...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Feb 18, 2026